🔗 Visit the ClinicalTrials.gov page for NCT01676649
| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Checkpoint modulation in melanoma: an update on ipilimumab and future directions. | Curr Oncol Rep | 2013 | 0.94 |
| 2 | Immune checkpoint blockade in cancer treatment: a double-edged sword cross-targeting the host as an "innocent bystander". | Toxins (Basel) | 2014 | 0.92 |